Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC PatientsL. Mezquita,E. Auclin,R. Ferrara,C. Caramella,M. Charrier,J. Remon,D. Planchard,S. Ponce,L. Paz-Ares,J. Lahmar,L. Leroy,C. Audigier-Valette, J. Zeron-Medina,P. Garrido,G. Zalcman,J. Mazieres,J. Adam,N. Chaput,J. Soria,B. BesseJournal of Thoracic Oncology（2017）引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
